Navigation Links
New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Date:5/31/2008

- Data From Phase 3 Study Presented at ASCO -

COLLEGEVILLE, Pa., May 31 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced results of a three-arm phase 3 clinical trial that show patients with relapsed and/or refractory mantle cell lymphoma (MCL), a form of non-Hodgkin's lymphoma, treated with the mTOR (mammalian target of rapamycin) inhibitor TORISEL(R) (temsirolimus) experienced a statistically significant improvement in median progression-free survival (PFS), compared with single-agent therapy selected by the investigator (4.8 months vs. 1.9 months, P=0.0009). These results are being presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

"Relapsed/refractory mantle cell lymphoma is extremely difficult to treat, and this is the first comparative phase 3 study to show a significant improvement in progression-free survival for these patients," says Georg Hess, M.D., Johannes Gutenberg-Universitat, Mainz, Germany. "These data further support the antitumor activity seen in phase 2 studies of temsirolimus in relapsed/refractory mantle cell lymphoma and indicate that mTOR inhibition may be a viable approach in this disease area."

MCL accounts for approximately 6 percent of non-Hodgkin's lymphoma cases.

"These findings reinforce the clinical potential of mTOR inhibition with TORISEL. Wyeth is committed to the continued exploration of mTOR inhibition with TORISEL for the treatment of a variety of cancers," says Joseph S. Camardo, M.D., Senior Vice President, Global Medical Affairs, Wyeth Pharmaceuticals.

TORISEL was approved in May 2007 for the treatment of advanced renal cell carcinoma (RCC) and is the only
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
3. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
4. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
5. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
6. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
7. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
8. TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
9. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
10. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
11. Tailored Clopidogrel Dosing Improves PCI Outcomes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RIDGE, Mass. and TOKYO, Dec. 1 Gal...ounced today the further extension of their resear...is latest extension increases the collaboration te...unding to approximately $90 million. The companie...th the goal of discovering and developing first-in...
(Date:12/1/2009)...RWATER, Fla., Dec. 1 CCS Medical, ...cal supplies, today announced that it has received...for District of Delaware (the "Court") for its bid...nd proposed sale of substantially all of its asset...009, the Court approved bidding procedures for the...
(Date:12/1/2009)...W YORK, Dec. 1 WebMD Hea...health information, today announced the honorees o...annual WebMD Health Heroes honor Americans with ex...erance, who lead an effort to help others achieve ...com.com/cgi-bin/prnh/20091201/NY18114 ) ,, "We...
Breaking Medicine Technology:Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3Austin Cosmetic Dentist Offers 2415 000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 60974 1Austin Cosmetic Dentist Offers 2415 000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 60974 2Austin Cosmetic Dentist Offers 2415 000 Worth of Dental Work in Most Interesting Patient in the World Video Contest 60974 3United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 1United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 2United States Olympic Committee Announces D I S C Sports and Spine Center as an Official Medical Services Provider 60972 3FHS Corp Announces Partnership with Vecna Technologies 60970 1FHS Corp Announces Partnership with Vecna Technologies 60970 2
(Date:12/1/2009)... in Central and South America, study finds , ...0 percent of intensive care unit patients worldwid...dying in the hospital, a new study finds. , Res...May 8, 2007) on 13,796 patients, aged 18 and older...1 percent of patients were classified as infected ...
(Date:12/1/2009)...cination because pandemic,s course remains unpredi...ws) -- A U.S. health official said Tuesday that H1...ationally, but many experts agreed the virus could...s now widespread in 32 states -- down from 43 stat...r of the U.S. Centers for Disease Control and Prev...
(Date:12/1/2009)... Practitioners of any medical, legal or bus...eathing a sigh of relief this week with the releas...cation, released over the holiday weekend, allows ...cordings to do so quickly and seamlessly using jus... (PRWEB) December 1, 2009 -- The iPhone App, relea...
(Date:12/1/2009)... , SMITHFIELD, R.I., Dec. 1 /PRNewswire/ ...bad assumptions are hazardous and can result in in...ent regulation, a handful of persistent bad assump...tiveness of occupational Hearing Conservation Pro...free, white paper from Howard Leight, " Bad Ass...
(Date:12/1/2009)...NGTON, Dec. 1 Individua...e likely than those with traditional coverage to e... more engaged in wellness programs, and to be more...r in holding down costs, according to survey resul...fit Research Institute (EBRI). ,, At the same ...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 2Health News:New White Paper Details Six Common Bad Assumptions About Hearing Protection 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4
...o have optic nerve damage might be at an increased...chers involved 25 people with visual impairment. T... followed for 14 days, and their results were comp...e sleepiness than those with normal sight and peop...
...al called parthenolide is successful in destroying...widely available plant of North America, called fe... treat migraine and rheumatoid arthritis, but this...h and continuation of the disease leukemia. ...
...vitamin B12 are safe and effective in reducing the...aving a stroke . According to researchers stroke p...hip fracture than their healthy peers due to highe... determine if folic acid and vitamin B12 decreases...
...ve disorder where there is a loss of normal bone d...nate if taken daily for 10 years can increase bone...lendronate, have been used for years to treat oste...e next two years. Then for the next five years, wo...
...to children suffering from attention deficit hyper...bility of cancer. // Although the drug Rital...ncer in animals, this is the first time any study ...alth, The University of Texas, in a study that’s g...
...rs don’t have to use a lot of force or pressure to...body has its own energy or "biomagnetic field" pro...eld can be altered by acupuncture needles, light a... this type of energy medicine works. Orthopedic su...
Other Medicine News:
...h specifically designed for laparoscopic hernia re... issues associated with laparoscopic procedures. M...enhanced maneuverability and retains a flat profil...h is the culmination of input and insight from lap...
...the treatment of all primary and recurrent indirec...t advantages over a conventional suture technique,... in a complete tension-free repair technique. The ...tation, and fewer recurrences.,The entire operati...
... wavelength with a unique flat beam profile to max... beam profile consistently delivers energy in the ...Lyra-I uniquely avoids high peak powers ensuring p...y patented continuous parallel contact cooling tha...
...orrhaphy. MERSILENE Polyester Fiber Mesh is a high...cellent strength, durability and surgical adaptabi...ssue ingrowth.,Mersilene Polyester Fiber Mesh is ...ame material used to make Mersilene Polyester Fibe...
Medicine Products: